The hippocampus is often injured in neonatal stroke. We have investigated the effect of erythropoietin (EPO) on oxygen-glucose deprived hippocampal slices and hypoxic progenitor cells. EPO improved survival of the organotypic hippocampal slices with significantly less cell death in the dentate gyrus and an increased number of proliferating cells 4-5 days after insult. Significantly fewer markers of neurogenesis were seen after the insult but when EPO was added to the culture medium, neurogenesis was sustained. When hippocampal progenitor cultures were stimulated into differentiation, more cells chose a neuronal cell fate when treated with EPO. These findings support the hypothesis that EPO not only prevents ischemia induced cell death but promotes neuronal cell fate commitment in in vitro models of neonatal stroke.
Introduction
Stroke in the neonatal period occurs in 1/4000 and is as common as in the adult (Nelson, 2007) , with over 80% of the surviving newborns having neurodevelopmental sequelae (Lee et al., 2005) . The pathological process of neonatal stroke is a dynamic process, evolving weeks after the event, through phases of oxidative stress, inflammation and repair (Ferriero, 2004) . Neuroprotective therapies are being investigated, each targeting a specific step of the injury response (Gonzalez and Ferriero, 2008) .
Many studies now confirm that neurogenesis occurs throughout the life span of mammalian and non-mammalian species (Altman, 1969; Alvarez-Buylla et al., 2002) . The subventricular zone (SVZ) and the dentate gyrus (DG) of the hippocampus are the two brain regions where adult neurogenesis occurs (Gage, 2000) . The role of the hippocampus in learning and memory has been known for decades (Milner, 1972) and is commonly injured in stroke (Kadam et al., 2008) . Increased neurogenesis is the intrinsic response of adult brain to ischemic and traumatic injuries (Dash et al., 2001; Parent et al., 2002) with increased neural progenitor cell proliferation occurring in adult models of global and focal ischemia (Jin et al., 2001; Liu et al., 1998) .
Most of the surviving newly formed cells in the DG differentiate into mature neurons by 3-4 weeks after ischemia, whereas about 10-20% of the newly generated cells differentiate into astrocytes in the granule cell layer and the hippocampal hilus (Komitova et al., 2006) . In the newborn brain, however, oligogenesis is favored over neurogenesis after hypoxia-ischemia (Zaidi et al., 2004) .
Erythropoietin (EPO) is a cytokine superfamily glycoprotein under the control of the oxygen-sensitive transcription factor hypoxiainducible factor-1 (HIF-1). EPO-EPO receptor (EPOR) signaling is required for normal brain development (Juul, 2002) . EPOR has been demonstrated on neurons, astrocytes, microglia and oligodendrocytes (Nagai et al., 2001) . The basal expression of EPO is found in neurons and astrocytes, while post-ischemic EPO expression is localized to endothelial cells, microglia/macrophage-like cells, and reactive astrocytes (Bernaudin et al., 1999) . In adult and neonatal animal models, EPO has a neuroprotective role when administered exogenously through anti-apoptosis, neuroregeneration and anti-inflammation (Gonzalez et al., 2007; Noguchi et al., 2007; Sola et al., 2005) . EPO can stimulate neuronal progenitor cell production from pluripotent progenitor cells (Shingo et al., 2001 ) and can increase both neurogenesis in the subventricular zone and migration of neuronal progenitors into the ischemic cortex and striatum of neonatal rats (Iwai et al., 2007) . However, there are no existing data regarding EPO effects on neuronal survival and neurogenesis in the hippocampus after hypoxia-ischemia in the neonatal period. Therefore, we hypothesized that EPO would ameliorate cell death in the dentate gyrus of Neurobiology of Disease 38 (2010) 259-265 
